FDA Inspection
KYMOS Pharma Services S.LKYMOS Pharma Services S.L – FDA Inspection, Jul 18, 2017
Record Details
This FDA Inspection record concerns KYMOS Pharma Services S.L, with an inspection on July 18, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · bc5674c3-002b-4f3b-8fc2-8cb154690b4f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1019455
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
8- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.160(a)Deviations from laboratory control requirements
- 21 CFR 211.68(b)Backup file not maintained
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.194(a)Complete test data included in records
- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of KYMOS Pharma Services S.L
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 14, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 17, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 23, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for KYMOS Pharma Services S.L
- FDA Inspection 1297704 - 2024-03-14
- FDA Inspection 1207132 - 2021-03-17
- FDA Inspection 1123784 - 2018-03-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.